Correlation Between Neuropace and SANUWAVE Health
Can any of the company-specific risk be diversified away by investing in both Neuropace and SANUWAVE Health at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neuropace and SANUWAVE Health into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neuropace and SANUWAVE Health, you can compare the effects of market volatilities on Neuropace and SANUWAVE Health and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neuropace with a short position of SANUWAVE Health. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neuropace and SANUWAVE Health.
Diversification Opportunities for Neuropace and SANUWAVE Health
0.79 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Neuropace and SANUWAVE is 0.79. Overlapping area represents the amount of risk that can be diversified away by holding Neuropace and SANUWAVE Health in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SANUWAVE Health and Neuropace is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neuropace are associated (or correlated) with SANUWAVE Health. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SANUWAVE Health has no effect on the direction of Neuropace i.e., Neuropace and SANUWAVE Health go up and down completely randomly.
Pair Corralation between Neuropace and SANUWAVE Health
Given the investment horizon of 90 days Neuropace is expected to generate 1.57 times less return on investment than SANUWAVE Health. But when comparing it to its historical volatility, Neuropace is 1.5 times less risky than SANUWAVE Health. It trades about 0.19 of its potential returns per unit of risk. SANUWAVE Health is currently generating about 0.2 of returns per unit of risk over similar time horizon. If you would invest 1,985 in SANUWAVE Health on October 10, 2024 and sell it today you would earn a total of 415.00 from holding SANUWAVE Health or generate 20.91% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Neuropace vs. SANUWAVE Health
Performance |
Timeline |
Neuropace |
SANUWAVE Health |
Neuropace and SANUWAVE Health Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Neuropace and SANUWAVE Health
The main advantage of trading using opposite Neuropace and SANUWAVE Health positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neuropace position performs unexpectedly, SANUWAVE Health can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SANUWAVE Health will offset losses from the drop in SANUWAVE Health's long position.Neuropace vs. Electromed | Neuropace vs. Orthopediatrics Corp | Neuropace vs. SurModics | Neuropace vs. Paragon 28 |
SANUWAVE Health vs. Rafarma Pharmaceuticals | SANUWAVE Health vs. GulfSlope Energy | SANUWAVE Health vs. TSS, Common Stock |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |